1. Catalogs
  2. Fisioline
  3. LUMIX 100 and LUMIX 250

LUMIX 100 and LUMIX 250

LUMIX 100 and LUMIX 250

LUMIX 100 and LUMIX 250

Product catalog summary
Introduction
Fisioline® has been a leader in laser technology since 1985, developing high-power pulsed lasers in collaboration with universities. The Lumix® 100 and Lumix® 250 are their latest innovations, featuring superpulsed high power lasers with peak powers between 1600W and 2500W.

Specifications
The Lumix® 100 and Lumix® 250 operate at a wavelength of 905 nanometers, essential for deep tissue penetration. They utilize multidiodic collimation and single spot overlap for uniform irradiation, with spot sizes ranging from 2 cm to 6 cm.

Technological Features
These lasers offer pulsed and superpulsed emissions, adjustable peak power, and high average powers. The P.I.E. System and nanotechnology pulses enhance therapeutic efficacy. They are FDA approved and have a wide frequency adjustment range for diverse medical applications.

Therapeutic Effects
The lasers provide analgesic, anti-edema, anti-inflammatory, and photobiostimulant effects, enhancing ATP production, protein synthesis, immune defense, and bone formation, aiding tissue regeneration and healing.

Applications
They are indicated for bone and tissue regeneration, pain therapy, post-traumatic and sports medicine, anti-inflammatory treatments, and rehabilitation therapy, effectively treating conditions like tendinitis, arthritis, and neuropathies.

Interactive Technologies
The Lumix® 100 and Lumix® 250 feature an intuitive touch screen interface for easy control of energy dosage and treatment parameters. The Wizard software guides users through preset protocols and allows for personalized treatment programs.

Research and Publications
Fisioline® has contributed to numerous scientific studies and publications, demonstrating the efficacy of their laser technology in various medical applications.

Research Studies
Studies indicate that Low Level Laser Therapy (LLLT) is effective in managing pain in osteonecrosis, increasing osteoblast activity, promoting chondrocyte proliferation, reducing inflammatory cytokine expression, and managing medication-related osteonecrosis of the jaw.

Technical Specifications
The LUMIX models are classified as Class I type B/BF electromedical equipment and Class IIb medical devices. They operate on 100-240V, 50/60Hz power supply, with Class 4 laser sources and pulsed/superpulsed modes. They feature a 7’’ TFT color touch-screen with programmable timer and safety features, complying with EU MDR 2017/745.

Product Details
The LUMIX250R3 has a peak power of 2500 W and average power of 6 W, the LUMIX100R3 has a peak power of 1600 W and average power of 3 W, and the LUMIXCPS2HP has a peak power of 400 W and average power of 1.3 W.

Conclusion
The document underscores the potential of laser therapy in medical treatments, supported by various studies and detailed technical specifications of the LUMIX laser models.
See more

Catalog excerpts

LUMIX 100 and LUMIX 250-1

High Frequency Power Lasers 100 250 The highest peak power in multidiodic lasers: up to 2500W

 Open the catalog to page 1
LUMIX 100 and LUMIX 250-2

Since 1985 Fisioline® produces technologically advanced laser equipment. The design collaboration of its engineers with internationally renowned Universities has enabled Fisioline® to be, since 1993, the first Italian company to build high-power pulsed lasers, thus opening a new frontier in this type of equipment. Fisioline® continues in its technological evolution with the brand new Lumix® 100 and Lumix® 250 SUPERPULSED HIGH POWER LASERS (H.F.P.L.® High Frequency Power Laser Fisioline®). Lumix® 100 and Lumix® 250 are the latest Fisioline® innovation derived from over 40 years of scientific research,...

 Open the catalog to page 2
LUMIX 100 and LUMIX 250-3

a revolution in laser therapy From nanotechnology the nano-pulses of 70ns ® 2021 FISIOLINE IS THE FIRST COMPANY IN THE WORLD TO INTRODUCE THE PHOTONIC INTERFERENCIAL EMISSION P.I.E. SYSTEM AND THE PEAK POWER ADJUSTABLE ON 3 LEVELS. ® Lumix 100 and Lumix 250 emit the light beam within the nanosecond range. The brevity and specificity of the light beam limits the heat emission to the surrounding tissues, concentrating efficacy only where needed. The nanoimpulses allow to supply large amounts of energy without elevated thermal cutaneous effects, in total safety. The real Superpulsation The use of...

 Open the catalog to page 3
LUMIX 100 and LUMIX 250-4

Indications Based on the type of pathology being treated, on the modalities and doses, laser treatments increases the pain threshold through direct action on nociceptive nerve endings and by indirectly increasing endorphins. Moreover, the laser induces hyperemia and macrophage activation, reducing ischemia and local stasis of endogeneous nociceptive tissues, exclude the onset of other possible sources of pain and inflammation. Finally, the recovery of the cellular membrane potential interrupts the vicious circle of contracturevasoconstriction-pain and resolves the inflammation. Concerning tissue...

 Open the catalog to page 4
LUMIX 100 and LUMIX 250-5

High Fisioline technology in dynamic, powerful and versatile lasers ® Matching to preset protocols of tutorial video available on board Articulated arm for automatic treatments Preset therapeutic protocols Wide colour touch-screen display with simple divided by body area USB port for software update Therapeutic handpiece with Summary dashboard of the pressure insertion of the spacers erogation parameters Spacers according to the area to treat (diameter 30 and 60mm) Ergonomic trolley with swivel wheels Lumix® C.P.S.® 2 High Power version The highest peak power in multidiodic portable lasers: 400...

 Open the catalog to page 5
LUMIX 100 and LUMIX 250-6

Our scientific studies Effect of superpulsed laser irradiation on bone formation in a human osteoblast-like cell line, G. Martinasso, M. Mozzati, R. Pol, R.A. Canuto, G. Muzio - Department of Medicine and Experimental Oncology Turin University, Turin, Italy. The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study. Umberto Romeo, DDS1, Alessandro Del Vecchio, DDS, Mauro Capocci, DDS1, Claudia Maggiore, MD, DDS2, Maurizio Ripari, MD, DDS1 - “Sapienza" University of Rome, Rome, Italy. Studio preliminare, il laser nel trattamento di lesioni in pazienti...

 Open the catalog to page 6
LUMIX 100 and LUMIX 250-7

Borgata Molino, 29 12060 VERDUNO (CN) • ITALY Tel.: +39.0172.470432-0172.470433 [email protected] www.fisioline.com Ed. 10/2025 Dato I'evolversi della tecnologia ed il continuo aggiornamento della produzione, le caratteristiche tecniche e dimensionali delle apparecchiature descritte nel presente catalogo possono subire variazioni.

 Open the catalog to page 7
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.